Sickle Cell Warrior Program from The National Marrow Donor Program® (NMDP)/Be The Match® Expands Access to Bone Marrow Transplant as a Curative Treatment

2 years ago

During Sickle Cell Awareness Month, NMPD/Be The Match reminds individuals to visit SickleCellConnect.com to access essential resources, learn more about…

Viemed Healthcare to Participate in Upcoming Investor Conferences

2 years ago

LAFAYETTE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national…

Ultragenyx to Participate at Investor Conferences in September

2 years ago

Citi BioPharma Conference on September 6 in Boston Morgan Stanley Healthcare Conference on September 12 in New York City NOVATO,…

Smart for Life Appoints Cindy Brynteson, RN, to the Company’s Advisory Board

2 years ago

Prominent Health & Wellness Sector Thought Leader and AuthorMIAMI, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq:…

The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy

2 years ago

LOS ANGELES, Aug. 31, 2023 (GLOBE NEWSWIRE) --  The International Myeloma Foundation (IMF) announced today that global leader and patient…

Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer

2 years ago

Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inhibitor BMF-219…

Cerevance Announces Presentation at the 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium

2 years ago

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,…

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

2 years ago

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs…